A Pilot Study to Evaluate PureWick for Nocturia

Status Suspended

Clinical Trial Summary

This is a single-center prospective pilot study of PureWick used as a management for nocturia and reduction of nighttime falls associated with going to the bathroom. Subjects are followed up to 3 months after the intervention. As a pilot study, it is expected that a 3-month follow-up will adequately capture urinary and sleep outcomes data and any adverse events related or unrelated to the study device.

Clinical Trial Description

Nocturia is a highly prevalent condition among older adults, significantly affecting the quality of life as well as putting them at an increased risk of falls and fractures. In those 65 and older, accidental falls are identified as the leading cause of injury and death. The chance of falling increases from 30% to 50% with age greater than 85 years. A study identified that in 1508 ambulatory men and women, nighttime urination of 2 times at night is associated with increased risk of falls (OR=1.84, 95% CI 1.05-3.22), with significantly higher risks when it increased to 3 or more times at night (OR=2.15, CI 95% -1.04-4.44). Incontinence management that reduces the need to get out of bed will lead to reduced risk of falls and unintentional injury fatalities. The PureWick Urine Collection System is intended for non-invasive urine output management. It pulls urine through tubing that is connected to a collection canister for proper disposal. It is designed to be used by patients, caregivers, or healthcare professionals in both home environments and professional care facilities. The PureWick System allows individuals to void while still in bed, demonstrating the potential to reduce the risks of falls associated with nighttime voids in men and women with nocturia. We hypothesize that this will also improve sleep quality and overall quality of life. ;

Study Design

Related Conditions & MeSH terms

Nocturia

Clinical Trial Details

NCT number	NCT05090722
Study type	Interventional
Source	Weill Medical College of Cornell University
Contact
Status	Suspended
Phase	N/A
Start date	December 16, 2021
Completion date	October 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03623880` - Enhancing Behavioral Treatment for Women With Pelvic Floor Disorders	N/A
Completed	`NCT02904759` - Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Male Subjects	Phase 3
Completed	`NCT02905682` - Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female Subjects	Phase 3
Completed	`NCT02835846` - Investigation of the Effect of the Female Urinary Microbiome on Incontinence	Phase 4
Completed	`NCT01694498` - Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Men	Phase 2
Completed	`NCT01684800` - Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Women	Phase 2
Completed	`NCT01520948` - Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease	Phase 3
Completed	`NCT01222598` - A Study of Minirin Melt in Patients With Nocturia	N/A
Recruiting	`NCT04305743` - Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A	Phase 4
Completed	`NCT01486706` - Efficacy and Safety of Gabapentin in Treating Overactive Bladder	Phase 2/Phase 3
Completed	`NCT04528784` - Feasibility Study of Transcutaneous Tibial Nerve Stimulation for Urinary Symptoms in People With Multiple Sclerosis	N/A
Recruiting	`NCT05874375` - UCon Treatment of Overactive Bladder (OAB) in Males	N/A
Completed	`NCT01223937` - Investigation of the Superiority Effect of Desmopressin to Placebo in Terms of Night Voids Reduction in Nocturia Adult Female Patients	Phase 3
Withdrawn	`NCT01018225` - Exploratory Study Evaluating the Effects of Darifenacin on Nocturia, Sleep and Daytime Wakefulness	Phase 4
Completed	`NCT05222477` - Abdominal Muscle Exercises on Nocturia and Sleep Quality in Women With Type 2 Diabetes	N/A
Withdrawn	`NCT02961114` - Use of Autologous Adipose-Derived Stem/Stromal Cells (AD-cSVF) in Symptomatic Benign Prostate Hypertrophy	Phase 1/Phase 2
Completed	`NCT02440841` - Study in Healthy Male Subjects to Evaluate the Effect of Itraconazole and Rifampicin on the PK of Fedovapagon	Phase 1
Completed	`NCT02068560` - The Effect of Gender on Antidiuresis - Evaluated by Graded Low Dose Desmopressin Infusion	N/A
Completed	`NCT01357356` - Multicenter Study to Investigate SER120 Nasal Spray Formulations in Patients With Nocturia	Phase 2/Phase 3
Completed	`NCT02151253` - Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia	Phase 2/Phase 3